SkoogBRunmarkerBWinbladS. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy. Brain2012; 135: 900–911.
2.
HutchinsonJBurkeTHutchinsonM. Neuropsychological assessment in multiple sclerosis: Methodological issues and concerns. Mult Scler1996; 2: 57–65.
3.
PortaccioEStromilloMLGorettiB. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology2009; 73: 498–503.
4.
AmatoMPPortaccioEGorettiB; TuSCIMS Study Group. Relevance of cognitive deterioration in early relapsing-remitting MS: A 3-year follow-up study. Mult Scler2010; 16: 1474–1482.
5.
AmatoMPRazzoliniLGorettiB. Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study. Neurology2013; 80: 1728–1733.
6.
NiccolaiCPortaccioEGorettiB. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients. BMC Neurol2015; 15: 204.
7.
LangdonDWAmatoMPBoringaJ. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler2012; 18: 891–898.
8.
RaoS. A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.
9.
AmatoMPLangdonDMontalbanX. Treatment of cognitive impairment in multiple sclerosis: Position paper. J Neurol2013; 260: 1452–1468.
10.
De StefanoNStromilloMLGiorgioA. Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry2016; 87: 93–99.